Behind The Knife: The Surgery Podcast Podcast Download - Alle Folgen kostenlos herunterladen

Journal Review in Thoracic Surgery: Empowering IMGs in CT Surgery - the Time to Act is Now

06.08.2026, 07:00

Navigating the path to becoming a surgeon in the US as an International Medical Graduate (IMG) can definitely have its hurdles. In this episode we sit down with Professor of Surgery, Dr. Ourania Preventza about her journey as an IMG, and how to break down the barriers in one of the most competitive surgical subspecialties. Dr. Preventza teaches us why sponsorship is invaluable, and how we as a surgical community can help support this vulnerable group of providers. With years of experience to offer, both as an IMG herself, and now as a fierce advocate and mentor for trainees, this interview with Dr. Preventza is not one to miss.

References:
https://www.jtcvsopen.org/article/S2666-2736(25)00059-2/fulltext
The current landscape and challenges facing international medical graduates in cardiothoracic surgery training

https://pubmed.ncbi.nlm.nih.gov/39886768/
International Medical Graduates in Academic Cardiothoracic Surgery

https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S2666273625002840?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2666273625002840%3Fshowall%3Dtrue&referrer=https:%2F%2Fpubmed.ncbi.nlm.nih.gov%2F
A career in cardiothoracic surgery in the United States: Guidance and resources for international medical graduates

https://jtd.amegroups.org/article/view/38164/html
US women in Thoracic Surgery: Reflections on the Past and Opportunities for the Future

Episode herunterladen

Clinical Challenges in Burn Surgery: Have Some Skin (Substitutes) In the Game

03.08.2026, 07:00

Join our burn team as they dive into the complex world of skin substitutes in burn care, breaking down a practical four-axis framework to help clinicians navigate product selection, patient factors, and clinical goals when managing massive burn injuries.

Hosts:
- Kathleen Romanowski – University of California Davis Hospital, Shriners Hospital Sacramento
- Laura Johnson – Grady Memorial Hospital
- Lauren Nosanov – Grady Memorial Hospital
- Victoria Miles – Louisiana State University Health Science Center, University Medical Center New Orleans

Learning objectives:
1. Classify skin substitutes along four axes: layer replaced, cellularity, origin, and duration.
2. Integrate wound, patient, phase-of-care, and goal factors to select an appropriate skin substitute or combination strategy.
3. Critically appraise the evidence base for skin substitutes, including industry influence and the distinction between adjunctive tools and definitive autologous coverage.

If you would like the table mentioned in the episode, please email hello@behindtheknife.org.

Episode herunterladen

Power, Partnerships, and the Reality of Global Surgery Collaboration

30.07.2026, 07:00

In this episode of the Behind the Knife Global Surgery Series, we take a closer look at the real-world complexity of global surgery partnerships between high-income institutions and partners in the Global South. Words like equity, bidirectionality, partnership, and decolonization are used often in global surgery—but what do they actually mean when funding, mobility, research access, publication opportunities, and institutional power are unequally distributed?

Host Mike Mallah is joined by Dr. Hugo Stark from George Hospital in South Africa and Dr. Sydney Bertram from Emory for a candid discussion about the benefits and tensions of collaborations in an unequal world. Together, they explore how global surgery partnerships can create meaningful educational and clinical value, how good intentions can still reproduce unequal systems, and how surgeons can build partnerships that are locally useful, honest about power, and ultimately centered on better surgical care for patients.

Hosts/Guests:

- Mike M. Mallah, MD, FACS, FICS
Director of Global Surgery at Medical University of South Carolina
@MikeMMallahMD
@MUSCGlobalSurg
mallahm@musc.edu

- Hugo Stark, MD
Head of Department - Surgery, George Hospital, Western Cape, South Africa
Head of Surgical Services, Central Karoo Region
Sydney Bertram, MD
General Surgery Resident, Emory University
Trainee Advisory Council, Consortium of Universities for Global Health
@Sydney_Bertram

Learning objectives:
• Describe how global surgery partnerships can provide educational, clinical, professional, and research value for both high-income and Global South partners.
• Identify how asymmetries in funding, mobility, publication access, and institutional agenda-setting can create inequity within otherwise well-intentioned global surgery partnerships.
• Discuss practical principles for ethical global surgery engagement, including centering local needs, avoiding extraction, building durable partnerships, and focusing on patient access to surgical decision-making.

Episode herunterladen

Clinical Challenges in Breast Surgery: The Fundamentals of Cancer Immunotherapy

27.07.2026, 07:00

Immune checkpoint inhibitors have rapidly reshaped care for triple-negative breast cancer (TNBC)—but surgical teams increasingly encounter their downstream perioperative consequences. In this episode, we define immunotherapy through the lens of checkpoint biology, review the landmark evidence supporting pembrolizumab in metastatic PD‑L1–positive TNBC (KEYNOTE‑355) and curative-intent stage II–III TNBC (KEYNOTE‑522), and translate immune-related adverse events (irAEs) into practical periop recognition, triage, and timing decisions—especially for endocrine, pulmonary, hepatic, dermatologic, and GI toxicities.

Hosts:
- Rashmi Kumar, MD, PhD
Resident, University of Michigan General Surgery Residency Program
Twitter/X: @RashmiJKumar
- Melissa Pilewskie, MD
Attending Breast Surgical Oncologist, Co-Director of the Weiser Family Center for Breast Cancer, Michigan Medicine
Twitter/X: @MPilewskie
- Stephanie Downs-Canner, MD
Attending Breast Surgical Oncologist & Physician-Scientist, Memorial Sloan Kettering Cancer Center, Program Director of the Breast Surgical Oncology Fellowship Training Program
Twitter/X: @SDownsCanner

Learning Objectives:

Define immunotherapy and immune checkpoint inhibition in breast cancer
Summarize current clinical indications and pivotal evidence for pembrolizumab in TNBC
Equip perioperative clinicians to identify and manage immune-related adverse events (irAEs) or side effects of immunotherapy.

Rationale for Immunotherapy in Breast Cancer Review

Selecting Triple Negative Breast Cancer Patients for Immunotherapy: https://pubmed.ncbi.nlm.nih.gov/37714640/

Landmark Clinical Trials Discussed in this Episode

KEYNOTE-355: https://pubmed.ncbi.nlm.nih.gov/33232653/
KEYNOTE-522: https://pubmed.ncbi.nlm.nih.gov/33232642/
IMpassion130: https://pubmed.ncbi.nlm.nih.gov/30345906/
IMpassion131: https://pubmed.ncbi.nlm.nih.gov/33930478/

Assessment of Surgical Outcomes in patients receiving chemoimmunotherapy

Surgical outcomes after neoadjuvant chemoimmunotherapy in triple-negative breast cancer: https://pubmed.ncbi.nlm.nih.gov/38332314/

Immune Related Adverse Events and Management

Schneider BJ, et al. Management of immune-related adverse events: https://pubmed.ncbi.nlm.nih.gov/34724392/
Brahmer JR, et al. SITC clinical practice guideline: https://pubmed.ncbi.nlm.nih.gov/34177534/

Episode herunterladen

Journal Review in Hernia Surgery: What is Bioresorbable Mesh and Is It Worth It?

23.07.2026, 07:00

Join our OHSY Hernia team to review the current landscape of bioresorbable meshes and a conversation considering “are they worth it?"

Hosts:

Dr. Maggie Bosley - @MBosleyMD
Dr. Sean Orenstein - @OrensteinSean
Dr. Amber Sandoval
Dr. Peter Ferrin

Institution: Oregon Health & Science University

References:
- Long-Term, Prospective, Multicenter Study of Poly-4-Hydroxybutyrate Mesh (Phasix Mesh) for Hernia Repair in Cohort at Risk for Complication: 60-Month Follow-Up
https://pubmed.ncbi.nlm.nih.gov/36102523/
- Multicenter, Prospective, Longitudinal Study of the Recurrence, Surgical Site Infection, and Quality of Life After Contaminated Ventral Hernia Repair Using Biosynthetic Absorbable Mesh: The COBRA Study
https://pubmed.ncbi.nlm.nih.gov/28009747/
- A prospective, multicenter trial of a long-term bioabsorbable mesh with Sepra technology in cohort of challenging laparoscopic ventral or incisional hernia repairs (ATLAS trial)
https://pubmed.ncbi.nlm.nih.gov/34976385/
- Biosynthetic mesh in hernia repair: A systematic review and meta-analysis
https://journals.lww.com/rhaw/fulltext/2024/07020/biosynthetic_mesh_in_hernia_repair__a_systematic.2.aspx

Episode herunterladen

Alle Episoden

Journal Review in Thoracic Surgery: Empowering IMGs in CT Surgery - the Time to Act is Now

Clinical Challenges in Burn Surgery: Have Some Skin (Substitutes) In the Game

Power, Partnerships, and the Reality of Global Surgery Collaboration

Clinical Challenges in Breast Surgery: The Fundamentals of Cancer Immunotherapy

Journal Review in Hernia Surgery: What is Bioresorbable Mesh and Is It Worth It?